These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 28935460)

  • 1. Myocardial fibrosis detected by magnetic resonance in systemic sclerosis patients - Relationship with biochemical and echocardiography parameters.
    Hromádka M; Seidlerová J; Suchý D; Rajdl D; Lhotský J; Ludvík J; Rokyta R; Baxa J
    Int J Cardiol; 2017 Dec; 249():448-453. PubMed ID: 28935460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subclinical myocardial inflammation and diffuse fibrosis are common in systemic sclerosis--a clinical study using myocardial T1-mapping and extracellular volume quantification.
    Ntusi NA; Piechnik SK; Francis JM; Ferreira VM; Rai AB; Matthews PM; Robson MD; Moon J; Wordsworth PB; Neubauer S; Karamitsos TD
    J Cardiovasc Magn Reson; 2014 Mar; 16(1):21. PubMed ID: 24593856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early myocardial and skeletal muscle interstitial remodelling in systemic sclerosis: insights from extracellular volume quantification using cardiovascular magnetic resonance.
    Barison A; Gargani L; De Marchi D; Aquaro GD; Guiducci S; Picano E; Cerinic MM; Pingitore A
    Eur Heart J Cardiovasc Imaging; 2015 Jan; 16(1):74-80. PubMed ID: 25190071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac Intravoxel Incoherent Motion Diffusion-Weighted Magnetic Resonance Imaging With T1 Mapping to Assess Myocardial Perfusion and Fibrosis in Systemic Sclerosis: Association With Cardiac Events From a Prospective Cohort Study.
    Terrier B; Dechartres A; Gouya H; Ben Arfi M; Bérézne A; Régent A; Dunogué B; London J; Cohen P; Guillevin L; Le Jeunne C; Legmann P; Vignaux O; Mouthon L
    Arthritis Rheumatol; 2020 Sep; 72(9):1571-1580. PubMed ID: 32379399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T1 mapping cardiac magnetic resonance imaging frequently detects subclinical diffuse myocardial fibrosis in systemic sclerosis patients.
    Poindron V; Chatelus E; Canuet M; Gottenberg JE; Arnaud L; Gangi A; Gavand PE; Guffroy A; Korganow AS; Germain P; Sibilia J; El Ghannudi S; Martin T
    Semin Arthritis Rheum; 2020 Feb; 50(1):128-134. PubMed ID: 31301817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffuse myocardial fibrosis precedes subclinical functional myocardial impairment and provides prognostic information in systemic sclerosis.
    Gotschy A; Jordan S; Stoeck CT; von Deuster C; Peer T; Gastl M; Vishnevskiy V; Wissmann L; Dobrota R; Mihai C; Becker MO; Maurer B; Kozerke S; Ruschitzka F; Distler O; Manka R
    Eur Heart J Cardiovasc Imaging; 2023 Feb; 24(3):373-382. PubMed ID: 35639682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffuse Myocardial Fibrosis and Inflammation in Rheumatoid Arthritis: Insights From CMR T1 Mapping.
    Ntusi NAB; Piechnik SK; Francis JM; Ferreira VM; Matthews PM; Robson MD; Wordsworth PB; Neubauer S; Karamitsos TD
    JACC Cardiovasc Imaging; 2015 May; 8(5):526-536. PubMed ID: 25890584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early myocardial damage and microvascular dysfunction in asymptomatic patients with systemic sclerosis: A cardiovascular magnetic resonance study with cold pressor test.
    Galea N; Rosato E; Gigante A; Borrazzo C; Fiorelli A; Barchetti G; Trombetta AC; Digiulio MA; Francone M; Catalano C; Carbone I
    PLoS One; 2020; 15(12):e0244282. PubMed ID: 33351821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffuse cardiac fibrosis quantification in early systemic sclerosis by magnetic resonance imaging and correlation with skin fibrosis.
    Lee DC; Hinchcliff ME; Sarnari R; Stark MM; Lee J; Koloms K; Hoffmann A; Carns M; Thakrar A; Aren K; Varga J; Aquino A; Carr JC; Benefield BC; Shah SJ
    J Scleroderma Relat Disord; 2018 Jun; 3(2):159-169. PubMed ID: 29808171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral microvascular function is linked to cardiac involvement on cardiovascular magnetic resonance in systemic sclerosis-related pulmonary arterial hypertension.
    Vos JL; Lemmers JMJ; El Messaoudi S; Snoeren M; van Dijk APJ; Duijnhouwer AL; Rodwell L; van Leuven SI; Post MC; Vonk MC; Nijveldt R
    Eur Heart J Cardiovasc Imaging; 2024 Apr; 25(5):708-717. PubMed ID: 38170546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of subclinical systemic sclerosis primary heart involvement characterised by microvasculopathy and myocardial fibrosis.
    Dumitru RB; Bissell LA; Erhayiem B; Fent G; Kidambi A; Swoboda P; Abignano G; Donica H; Burska A; Greenwood JP; Biglands J; Del Galdo F; Plein S; Buch MH
    Rheumatology (Oxford); 2021 Jun; 60(6):2934-2945. PubMed ID: 34080001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial Involvement Detected Using Cardiac Magnetic Resonance Imaging in Patients with Systemic Sclerosis: A Prospective Observational Study.
    Hromadka M; Baxa J; Seidlerova J; Miklik R; Rajdl D; Sudova V; Suchy D; Rokyta R
    J Clin Med; 2021 Nov; 10(22):. PubMed ID: 34830647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility of Hepatic T1-Mapping and Extracellular Volume Quantification on Routine Cardiac Magnetic Resonance Imaging in Patients with Infiltrative and Systemic Disorders.
    Dolan RS; Stillman AE; Davarpanah AH
    Acad Radiol; 2022 Apr; 29 Suppl 4():S100-S109. PubMed ID: 34702675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of diffuse myocardial fibrosis using CMR extracellular volume fraction and serum biomarkers of collagen turnover with histologic quantification as standard of reference.
    Foussier C; Barral PA; Jerosh-Herold M; Gariboldi V; Rapacchi S; Gallon A; Bartoli A; Bentatou Z; Guye M; Bernard M; Jacquier A
    Diagn Interv Imaging; 2021 Mar; 102(3):163-169. PubMed ID: 32830084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left ventricular dysfunction assessed by speckle-tracking strain analysis in patients with systemic sclerosis: relationship to functional capacity and ventricular arrhythmias.
    Yiu KH; Schouffoer AA; Marsan NA; Ninaber MK; Stolk J; Vlieland TV; Scherptong RW; Delgado V; Holman ER; Tse HF; Huizinga TW; Bax JJ; Schuerwegh AJ
    Arthritis Rheum; 2011 Dec; 63(12):3969-78. PubMed ID: 22127711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and laboratory predictions of myocardial inflammation as detected by cardiac magnetic resonance imaging in patients with systemic sclerosis: A pilot study.
    Tipparot T; Foocharoen C; Mahakkanukrauh A; Suwannaroj S; Nanagara R; Pussadhamma B; Chaosuwannakit N
    Int J Rheum Dis; 2019 Dec; 22(12):2125-2133. PubMed ID: 31659856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial fibrosis imaging based on T1-mapping and extracellular volume fraction (ECV) measurement in muscular dystrophy patients: diagnostic value compared with conventional late gadolinium enhancement (LGE) imaging.
    Florian A; Ludwig A; Rösch S; Yildiz H; Sechtem U; Yilmaz A
    Eur Heart J Cardiovasc Imaging; 2014 Sep; 15(9):1004-12. PubMed ID: 24686257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial T1 mapping and extracellular volume quantification as novel biomarkers in risk stratification of patients with systemic sclerosis.
    Bordonaro V; Bivort D; Dresselaers T; De Langhe E; Bogaert J; Symons R
    Clin Radiol; 2021 Feb; 76(2):162.e1-162.e8. PubMed ID: 33109349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Native T1 mapping in early diffuse and limited systemic sclerosis, and its association with diastolic function.
    Purevsuren M; Uehara M; Ishizuka M; Suzuki Y; Shimbo M; Kakuda N; Ishii S; Sumida H; Miyazaki M; Yamashita T; Yoshizaki A; Asano Y; Sato S; Hatano M; Komuro I
    J Cardiol; 2023 Aug; 82(2):100-107. PubMed ID: 36921691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth Differentiation Factor-15 (GDF-15) Level and Relation to Clinical Manifestations in Egyptian Systemic Sclerosis patients: Preliminary Data.
    Gamal SM; Elgengehy FT; Kamal A; El Bakry SA; Shabaan E; Elgendy A; Bassyouni IH
    Immunol Invest; 2017 Oct; 46(7):703-713. PubMed ID: 28872977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.